Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention? "window" Analysis from the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents)

Ajay J. Kirtane, Puja B. Parikh, Thomas D. Stuckey, Ke Xu, Bernhard Witzenbichler, Giora Weisz, Michael J. Rinaldi, Franz Josef Neumann, D. Christopher Metzger, Timothy D. Henry, David A. Cox, Peter L. Duffy, Bruce R. Brodie, Ernest L. Mazzaferri, Rupa Parvataneni, Akiko Maehara, Philippe Généreux, Roxana Mehran, Gregg W. Stone

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Is There an Ideal Level of Platelet P2Y<sub>12</sub>-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention? "window" Analysis from the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents)'. Together they form a unique fingerprint.

Medicine & Life Sciences